glp 1 and kidney transplant glp-1 outcomes news Receptor Agonist Use in Recipients in: Kidney Volume 17 Issue 8 (2025) Kidney Outcomes With Glucagon-Like Peptide-1 – Potential kidney-protective and other effects

If you have sleep apnea and want GLP-1 coverage through the OSA indication, ask your doctor about Zepbound instead

For patients on semaglutide who are concerned about losing strength, adding peptide therapy creates a dual approach: GLP-1 medications drive appetite control and fat reduction, while peptides support the anabolic environment muscles need to stay intact

Contact us today!

The alpha sub-unit is essentially identical to the alpha sub-units of the human pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), as well as to the alpha sub-unit of human thyroid-stimulating hormone (TSH)

Such treatment outcomes would benefit patients afflicted with AD and possibly those suffering from other neurodegenerative diseases